Skip to main content
Log in

Stereotactic Large Core Needle Biopsy for All Nonpalpable Breast Lesions?

  • Conference Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Background Stereotactic large-core needle biopsy (SLCNB) is a minimally invasive method for histological diagnosis of nonpalpable breast disease. We studied differences in cancer prevalence between a group of women referred through the national screening program and a non-screening group, and assessed whether the validity of SLCNB differed between these groups.

Methods A group of non-selective, consecutive patients presenting with a nonpalpable mammographic lesion, who participated in a recently conducted multicenter study regarding the accuracy of SLCNB in The Netherlands, were the basis for this study. Prevalence of carcinoma, predictive value of a benign diagnosis, sensitivity, and specificity rate of SLCNB were compared between the two groups.

Results Of the 1029 lesions in 972 patients included, 858 were evaluable. In 850/858 lesions (99.1%) the reason for referral was clear. The prevalence of cancer in the screening group (n = 511 lesions) was 64.0% (95%CI 59.8–68.2), versus 49.6% in the non-screening group (n = 339) (95%CI 44.2–54.9). Respective predictive values of a benign diagnosis on SLCNB were 97.0 versus 94.8% (non-significant). The sensitivity rates of SLCNB were 98.5% (screening; 95%CI 96.5–99.5) versus 95.2% (non-screening; 95%CI 90.8–97.9). Specificity rates were 97.8 (95%CI 94.5–99.4) and 99.4% (95%CI 96.8–100), respectively.

Conclusion Despite a significant difference in the prevalence of carcinoma, the accuracy of SLCNB did not show a statistically significant difference between both patient groups. Therefore, SLCNB appears accurate in diagnosing nonpalpable breast lesions both in screening and non-screening patient groups.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Fracheboud J, de Koning HJ, Beemsterboer PMM, Boer R, Hendriks JHCL, Verbeek ALM, van Ineveld BM, de Bruyn AE, van der Maas PJ: Nation-wide breast cancer screening in The Netherlands: results of initial and subsequent screening 1990–1995. Int J Cancer 75: 694–698, 1998

    Google Scholar 

  2. Kerlikowske K, Grady D, Rubin SM, Sanrock C, Ernster VL: Efficacy of screening mammography. A meta-analysis. JAMA 273(2): 149–154, 1995

    Google Scholar 

  3. Nyström L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Ryden S, Andersson I, Bjurstam N, Fagerberg G, Frisell J: Breast cancer screening with mammography: overview of swedish randomised trials. Lancet 341(8851): 973–978, 1993

    Google Scholar 

  4. Tabàr L, Vitak B, Tony HH, Yen MF, Duffy SW, Smith RA: Beyond randomized controlled trials: organized mammographic screening substantially reduces breast cancer mortality. Cancer 91(9): 1724–1731, 2001

    Google Scholar 

  5. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ: Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990–1998: comparison of observed with predicted mortality. BMJ 321: 665–669, 2000

    Google Scholar 

  6. Fracheboud J, de Koning HJ, Boer R, Groenewoud JH, Verbeek ALM, Broeders MJM, van Ineveld BM, Hendriks JHCL, de Bruyn AE, Holland R, van der Maas PJ: Nationwide breast cancer screening programme fully implemented in The Netherlands. The Breast 10(1): 6–11, 2001

    Google Scholar 

  7. Boer R, Koning HJ de, Oortmarssen GJ van, Maas PJ van der: In search of the best upper age limit for breast cancer screening. Eur J Cancer 31A: 2040–2043, 1995

    Google Scholar 

  8. Parker H, Lovin JD, Jobe WE, Luethke JM, Hopper KD, Yakes WF, Burke BJ: Stereotactic breast biopsy with a biopsy gun. Radiology 176: 741–747, 1990

    Google Scholar 

  9. Brenner RJ, Bassett LW, Fajardo LL, Dershaw DD, Evans WP 3rd, Hunt R, Lee C, Tocino I, Fisher P, McCombs M, Jackson VP, Feig SA, Mendelson EB, Margolin FR, Bird R, Sayre J: Stereotactic core-needle breast biopsy: a multiinstitutional prospective trial. Radiology 218(3): 866–872, 2001

    Google Scholar 

  10. Morrow M, Venta L, Stinson T, Bennett C: Prospective comparison of stereotactic core biopsy and surgical excision as diagnostic procedures for breast cancer patients. Ann Surg 233(4): 537–541, 2001

    Google Scholar 

  11. Verkooijen HM: Diagnostic accuracy of stereotactic large-core needle biopsy for nonpalpable breast disease: results of a multicenter prospective study with 95% surgical confirmation. Int J Cancer 2002, in press.

  12. Verkooijen HM, Peeters PHM, Buskens E, Koot VCM, Borel Rinkes IHM, Mali WPThM, van Vroonhoven ThJMV: Diagnostic accuracy of large-core needle biopsy for nonpalpable breast disease: a meta-analysis. Br J Cancer 82(5): 1017–1021, 2000

    Google Scholar 

  13. Verkooijen HM, Peeters PHM, Pijnappel RM, Koot VCM, Schipper MEI, Borel Rinkes IHM: Diagnostic accuracy of needle-localized open breast biopsy for impalpable breast disease. Br J Surg 87: 344–347, 2000

    Google Scholar 

  14. Moons KG, van Es GA, Deckers JW, Habbema JD, Grobbee DE: Limitations of sensitivity, specificity, likelihood ratio and Bayes theorem in assessing diagnostic probabilities: a clinical example. Epidemiology 8: 12–17, 1997

    Google Scholar 

  15. Burbank F, Parker SH: Methods for evaluating the quality of an image guided breast biopsy program. Sem Breast Dis 1: 71–83, 1998

    Google Scholar 

  16. Jackman RJ, Nowels KW, Rodriguez-Soto J, Marzoni FA, Finkelstein SD, Shephard MJ: Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: falsenegative and histologic underestimate rates after long-term follow up. Radiology 210: 799–805, 1999

    Google Scholar 

  17. Liberman L, Cohen MA, Dershaw DD, Abramson AF, Hann LE, Rosen PP: Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions. An indication for surgical biopsy. AJR 164: 1111–1113, 1995

    Google Scholar 

  18. Brown TA, Wall JW, Christensen ED, Smith DV, Holt CA, Carter PL, Patience TH, Babu SS, Williard WC: Atypical hyperplasia in the era of stereotactic core needle biopsy. J Surg Oncol 67: 168–173, 1998

    Google Scholar 

  19. Gadzala DE, Cederbom GJ, Bolton JS, McKinnon WM, Farr GH, Champaign J, Ordoyne K, Chung K, Fuhrman GM: Appropriate management of atypical ductal hyperplasia diagnosed by stereotactic core needle breast biopsy. Ann Surg Oncol 4: 283–286, 1997

    Google Scholar 

  20. Latosinsky S, Cornell D, Bear HD, Karp SE, Little S, Paredes ED: Evaluation of stereotactic core needle biopsy (SCNB) of the breast at a single institution. Breast Cancer Res Treat 60(3): 277–283, 2000

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoorntje, L., Peeters, P., Rinkes, I.B. et al. Stereotactic Large Core Needle Biopsy for All Nonpalpable Breast Lesions?. Breast Cancer Res Treat 73, 176–181 (2002). https://doi.org/10.1023/A:1015289903352

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015289903352

Navigation